Conjugation of Synthetic Cannabinoids JWH-018 and JWH-073, Metabolites by Human UDP-Glucuronosyltransferases

K2, a synthetic cannabinoid (SC), is an emerging drug of abuse touted as “legal marijuana” and marketed to young teens and first-time drug users. Symptoms associated with K2 use include extreme agitation, syncope, tachycardia, and visual and auditory hallucinations. One major challenge to clinicians...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chimalakonda, Krishna C., Bratton, Stacie M., Le, Vi-Huyen, Yiew, Kan Hui, Dineva, Anna, Moran, Cindy L., James, Laura P., Moran, Jeffery H., Radominska-Pandya, Anna
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society for Pharmacology and Experimental Therapeutics 2011
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3186213/
https://ncbi.nlm.nih.gov/pubmed/21746969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.111.040709
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia